Back to top
more

Align Technology (ALGN)

(Delayed Data from NSDQ)

$219.70 USD

219.70
828,351

+3.68 (1.70%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $219.71 +0.01 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 35% (163 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Genomic Health (GHDX) Oncotype DX Score Test Data Positive

Genomic Health (GHDX) forges ahead with development of Oncotype DX Breast Recurrence Score test.

    Boston Scientific Receives FDA Nod for Vercise DBS System

    Boston Scientific (BSX) forges ahead with initiatives to boost DBS portfolio under Neuromodulation business.

      Smith & Nephew's Rotation Medical Deal Aids Tissue Regen Arm

      Smith & Nephew's (SNN) completion of Rotation Medical acquisition appears highly strategic as this will consolidate the company's position in disruptive technologies and advance its overall growth.

        Hill-Rom (HRC) Banks on Strategic Buyouts, Competition Rife

        Hill-Rom's (HRC) upbeat long-term view buoys optimism.

          Inogen Rides on Solid Product Portfolio Amid Forex Woes

          Inogen's (INGN) expanding product portfolio is a key catalyst. Foreign exchange headwinds continue to hurt the company's growth trajectory.

            Omnicell's Rising Costs Affect Bottom Line Amid Competition

            Soft margin scenario is a headwind for Omnicell (OMCL). The company's strategic endeavors such as portfolio expansion, acquisitions and new market growth persistently escalate expenses.

              Myriad Genetics Presents Encouraging EndoPredict Test Data

              Myriad Genetics (MYGN) forges ahead with initiatives to boost the Molecular Diagnostics portfolio.

                NxStage Nx2me Connected Health Improves Home Hemodialysis

                NxStage Medical (NXTM) consistently looks to expand dialysis platform.

                  Tirthankar Chakraborty headshot

                  Buy These 4 Stocks With Excellent Earnings Growth

                  We have picked stocks that have displayed historical earnings growth and are also seeing a rise in quarterly and annual earnings estimates.

                    Varian Halcyon Gets ANVISA Registration, Grows in Oncology

                    Varian (VAR) consistently tries to expand in the global market with Halcyon system.

                      Genomic Health-Janssen Pharma Tie Up, GPS Test in Focus

                      Genomic Health (GHDX) focuses on notable partnerships to promote its Oncotype DX Genomic Prostate Score (GPS) test.

                        Myriad Genetics (MYGN) Presents Positive riskScore Test Data

                        Myriad Genetics (MYGN) presents positive riskScore data at the SABCS. With riskScore, the company intends to boost its myRisk Hereditary Cancer test suite.

                          Hologic's Panther Fusion Flu AdV/hMPV/RV Assay Wins FDA Nod

                          Hologic's (HOLX) recent spree of regulatory approvals for its array of products is encouraging.

                            Chemed Banks on Roto-Rooter Sales, Focuses on Vitas Revival

                            Chemed (CHE) continues to display robust performance in Roto-Rooter business on strength in core plumbing and drain cleaning service segments.

                              Walgreens Boots Invests in China to Fortify Retail Pharmacy

                              Walgreens Boots' (WBA) decision to buy a minority stake in Sinopharm Holding Guoda Drugstores is likely to leverage its global pharmacy expertise.

                                Edwards Lifesciences Buys Harpoon Medical, Expands Portfolio

                                Edwards Lifesciences (EW) expands Surgical Heart Valve Therapy segment with the buyout of Harpoon Medical.

                                  Hologic Banks on Molecular Diagnostics, Competition Rife

                                  Hologic (HOLX) gains on increasing market share and utilization of fully-automated Panther system.

                                    Here's Why You Should Invest in PetMed (PETS) Stock Now

                                    PetMed's (PETS) implements strategies to revitalize top line. It also offers a comprehensive portfolio.

                                      IDEXX Laboratories Banks on Global Prospects, CAG Strength

                                      IDEXX Laboratories (IDXX) rides on strength across all segments, especially CAG. Strong fundamentals buoy optimism.

                                        Align Technology Rides High on InvisAlign & Strategic Pacts

                                        Rising demand for InvisAlign products in the global teen market and the distribution agreement with Patterson Dental are major upsides for Align (ALGN).

                                          CVS-Aetna Deal: What's Hot, What's Not

                                          CVS Health (CVS) and Aetna consolidation to add a new dimension to healthcare landscape. However, critics believe the gain will be short-lived for the healthcare society.

                                            The Zacks Analyst Blog Highlights: CVS Health, Aetna, PetMed Express, Align Technology and Myriad Genetics

                                            The Zacks Analyst Blog Highlights: CVS Health, Aetna, PetMed Express, Align Technology and Myriad Genetics

                                              Quest Diagnostics Banks on Buyouts to Expand in Diagnostic

                                              Quest Diagnostics (DGX) actively pursues merger and acquisitions to solidify hold in the high-potential diagnostic information services market. Notably, Cleveland HeartLab buyout marks as the latest deal.

                                                Patterson Companies-SprintRay Deal to Boost Dental Unit

                                                Patterson Companies (PDCO) focuses on acquisitions to boost dental segment.

                                                  Why Align Technology (ALGN) is Poised to Beat Earnings Estimates Again

                                                  Align Technology (ALGN) is in a good position to beat earnings at its next report as it has a favorable Zacks Rank and positive Earnings ESP.